|
|
Post by JHam on May 7, 2020 16:00:20 GMT
I decided to take a small bet in this one at $.69. They produce silicone nitride for ceramic and silicone medical equipment. Silicon nitride is known to be effective in killing bacteria and viruses. They have done experiments showing 100% inactivation of H1N1 and feline viruses showing in less than 5 mins (the test was 5 mins but apparently the viruses are killed less than a minute. In their last conference call they said they hope to apply silicon nitride two items used in public such as ATM machines, doorhandles, stair banisters, etc...They also think they can use it on facial masks. There are lots of potentially huge very near term milestones in relation to COVID-19, such as patents for this technology, government funding, partnership news. From the SA article published yesterday: Profile: * Only $5 million market cap * No debt * Low float of only 9.8 million * Cash through March 2021 * Nasdaq extension (given compliance extension until December 2020) * Open gap at $1.25 * Number of PR’s in the near future likely * Missed by market SA article: seekingalpha.com/instablog/51660195-wallstreetanalyst/5442460-sintx-technologies-how-silicon-nitride-help-fight-coronavirusMarch call transcript: d1io3yog0oux5.cloudfront.net/_2e5e9446052382b10c77821d56166d33/sintx/db/359/3382/pdf/13700932_+TRX.pdf |
|
|
|
Post by JHam on May 8, 2020 16:44:41 GMT
Averaged down a bit today.
|
|
|
|
Post by JHam on Jun 22, 2020 10:08:48 GMT
Well damn! I had a medium position of this at $.72. Sold at $.80 a few weeks ago. Made a little money, but guess I should have held out for today's news. Up 300%+ premarket: seekingalpha.com/pr/17905991-sintx-technologies-announces-sars-covminus-2-testing-results
SINTX TECHNOLOGIES ANNOUNCES SARS-COV-2 TESTING RESULTS
Sat June 20, 2020 12:56 AM|GlobeNewswire|About: SINT
SALT LAKE CITY, UT, June 20, 2020 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (SINT) (“SINTX” or the “Company”), an original equipment manufacturer (OEM) ceramics company focused on silicon nitride and its applications, today announced that in a controlled laboratory study, the SARS-CoV-2 virus was inactivated when exposed to SINTX’s sintered silicon nitride powder. The Company expects to share additional data soon, once the findings are published in a rapid-review forum.
“The preliminary results are encouraging,” said Dr. Sonny Bal, CEO of SINTX. “The antiviral data are consistent with the well-established anti-bacterial properties of SINTX’s silicon nitride, and with previously reported effectiveness against several single-strand RNA viruses. Additional testing at independent, outside laboratories is in progress to corroborate the effectiveness of silicon nitride against SARS-CoV-2.”
SINTX is committed to the scientific integrity of its R&D programs and has invested heavily in the careful verification of its reported findings. No representations are made as to the effectiveness of silicon nitride in consumer products, whether medical or otherwise. Investors are cautioned against making any assumptions based on the experimental results reported herein.
About SINTX Technologies, Inc.
SINTX Technologies is an OEM ceramics company that develops and commercializes silicon nitride for medical and non-medical applications. The core strength of SINTX Technologies is the manufacturing, research, and development of silicon nitride ceramics for external partners. The Company manufactures silicon nitride material and components in its FDA registered and ISO 13485 certified facility. |
|
|
|
Post by JHam on Jun 25, 2020 2:01:55 GMT
They published the data today and the pps shot up to $2.57. That’s 270%+ from my initial opening position. The data is preliminary and needs some more verification. There are other trials ongoing which we should hear the results from soon. But if it silicone nitrate can really kill coronavirus within seconds this could really be a game changer. I’m looking to jump back in here if it dips back down into the low $1s: finance.yahoo.com/news/sintx-technologies-announces-publication-study-192000248.html |
|
|
|
Post by JHam on Jul 4, 2020 3:49:50 GMT
Pasting what I just wrote in the low float runners thread just for reference: They added 2,400,000 shares, so the new total is 19,378,777. Not great, however, with insider/institutional ownership calculated, the float is around 13/14M. So I'm still going to consider it a low floater. There are a lot of eyes on this stock though (31,000+ on ST), so I don't mind that it has the extra liquidity. Some misc. info about the value change after the ATM deal at the time compared to now, and the affect pf the dilution: At the time of the ATMo/s - 16,978,679 MC - $38.7M Pricing - $2.28 Currento/s - 19,378,777 MC - $28M Pps - $1.67 A $38.7M MC today (MC at the pricing) would give a pps of $2.01 The MC at the peak of the recent run up was around $60M, or about $3.06 post dilution (it ran to $3.50 pre-market). That's about 83% higher than where we are now, and that is before the real fireworks even happen. I said all of this to make the point, that while dilution hurts, at the moment this is still a pretty good value buy. Any news from here on out should take this above $50M pretty easily, just on hype/pump alone imo. If the news is really substantive then this could really go through the roof. Here is what they said in the data release PR: "The study and testing results show promise toward developing a new category of face masks for healthcare professionals and general consumers," said Bruce Lorange, Founder, and CEO, O2TODAY. "Face masks used by healthcare workers today can capture virus particles, but the virus can remain viable in the mask, even as long 7 days after use. Inclusion of silicon nitride technology into the mask may enhance personal safety while reducing the risk of disease spread."
"This antiviral discovery opens many new opportunities for SINTX. In composites, coatings, and mixtures, silicon nitride has maintained its antibacterial and osteogenic properties, even at small fractions. We believe that incorporating our material into a variety of commonly-touched surfaces will discourage viral spread, and contribute to global health by reducing the risk of disease," Dr. Bal added.
finance.yahoo.com/news/sintx-technologies-announces-publication-study-192000248.htmlIf they make a deal just with mask companies, this could prove to be the biggest COVID play of them all. I think another possibility is they make a deal with the gov't to incorporate silicon nitride into ppe (personal protective equipment). If any of these things happen $5 is definitely not out of the question, and that is being pretty conservative, imo. Nothing has changed in my thesis with SINT since my initial buy. Just at the time, not knowing the future of COVID and where this was all heading (also with my job etc...) I was trying to preserve cash. I didn't want to get stuck holding onto anything. One caveat here, is that they actually did two raises recently. The first one on June 23rd at $1.50 for $5.6M. So if there is another pop, they could even do another one. They ended Q1 with $8.2M in cash, so factoring in the burn from the end of March, I'd say they probably have somewhere around $15M CoH at the moment. This doesn't concern me too much because the near term upside is good. |
|
|
|
Post by JHam on Jul 6, 2020 19:04:28 GMT
Back in at $1.77.
|
|
|
|
Post by magnus123 on Jul 6, 2020 20:33:07 GMT
It looks really good at the moment. A lot of AH activity. Even without imminent news, we should move above $2. |
|
|
|
Post by JHam on Jul 7, 2020 1:44:45 GMT
It looks really good at the moment. A lot of AH activity. Even without imminent news, we should move above $2. Yeah, it not too fast! I need to buy more  With COVID not going away any time soon, this one has the potential to be a real game changer. Everyone is talking about a vaccine or therapeutics, but if they can make a dent in the transmission of surface to face infections, it would be huge. No one in the market or in everyday society is even thinking about this kind of prevention so when the big news hits it should get a lot of attention. |
|
|
|
Post by JHam on Jul 7, 2020 4:13:48 GMT
This is what happened the day they announced preliminary data. The pps even went as high as $3.50 pre-market.  I have to correct one thing in my post from the other day though. This jump happened prior to the two rounds of financing/dilution. So a $3.50 pps back then was around a $35M market cap. The market cap now is $30M so while we are still under the peak from the jump the other day, it is not as far apart. It was after all only a $5M market cap back in May when I opened this thread. That said $30M is still a bargain here if they make some COVID deals. Just be aware that the jump from $5M to $30M is purely COVID-related. This company really doesn't have much to show for its base business to this point, so any hiccup with their COVID program could send this back down to $5-10M market cap. |
|
|
|
Post by JHam on Jul 7, 2020 4:32:13 GMT
And FYI, the "great" Lionmaster from ST (I jokingly call him great, but he has 22K followers at SINT, and has a pretty good track record), just posted this: $SINT just got words company will issue Nasdaq compliant listing press by Wednesday. Expect institutions to load up SINT. Not sure if I agree that institutions will "load" up on a $2 stock, but any kind of news could rocket this up again. |
|
|
|
Post by JHam on Jul 9, 2020 13:22:47 GMT
www.globenewswire.com/news-release/2020/07/09/2060031/0/en/SINTX-Technologies-Announces-Closing-of-9-7-Million-Registered-Direct-Offerings-and-Provides-Business-Update.htmlSINTX Technologies Announces Closing of $9.7 Million Registered Direct Offerings and Provides Business Update
Update on Common Shares Outstanding
A summary of the Company’s Capitalization Table as of June 30, 2020, is shown below.
Warrants Outstanding 1,147,140
Options Outstanding (as of December 31, 2019) 377
Shares Available under 2017 Equity Incentive Plan 2,520
Total Potentially Dilutive Securities 1,150,037
Common Shares Outstanding (as of June 30, 2020) 19,430,913
Series B Outstanding (as converted)* 93,560
Series C Outstanding (as converted)** 35,778
Total Shares & Potentially Dilutive Securities 20,710,288
Total Debt Outstanding $ -
*126 Series B outstanding. Assuming conversion rate of 742.54:1.
**53 Series C outstanding. Assuming conversion rate of 675.05:1.
|
|
|
|
Post by magnus123 on Jul 9, 2020 14:26:20 GMT
Whats the cash position now?
|
|
|
|
Post by JHam on Jul 9, 2020 14:32:50 GMT
Whats the cash position now? Around $15M. |
|
|
|
Post by magnus123 on Jul 9, 2020 14:36:38 GMT
Whats the cash position now? Around $15M. That sounds very solid. With the dilution off the table now, i averaged up. |
|
|
|
Post by JHam on Jul 9, 2020 14:39:42 GMT
That sounds very solid. With the dilution off the table now, i averaged up. Back in May they still had cash through March 2021. With the added $9.7M they now probably have a runway through the end of 2021. |
|
|
|
Post by JHam on Jul 9, 2020 14:56:14 GMT
This is from the article in the first post in this thread, back when it was at a $5M market cap. Some of these catalysts have happened, but many still have not. In particular federal funding, partners, the invited paper.
“We are looking at patents and grants along these lines. We filed an antipathogenic patent that is very broad based and covers the antibacterial and antiviral properties of a material. And now, we’re filing new patents for consumer and medical devices based on the antiviral behavior of silicon nitride. We have hired an outside firm to leverage our knowledge and skill and get grant applications before the federal government. There are new funding opportunities coming out in light of the viral epidemic almost every day. So, there’s a huge opportunity for us to fund our R&D pathway.”
Therefore, shareholders can expect a number of PR’s in the near future.
Potential Game Changer
There are now some familiar scenes in public places around the world – people trying to open doors with their elbows, commuters studiously surfing their way through train journeys to avoid grabbing a handle, office workers rubbing down their desks each morning. In the areas worst hit by the new coronavirus, teams of workers in protective clothing have been dispatched to spray a fog of disinfectant in plazas, parks and public streets. Cleaning regimes in offices, hospitals, shops and restaurants have been increased. In some cities, well-meaning volunteers even venture out at night to scrub the keypads of cash machines. Like many respiratory viruses, including flu, Covid-19 can be spread in tiny droplets released from the nose and mouth of an infected person as they cough. A single cough can produce up to 3,000 droplets. These particles can land on other people, clothing and surfaces around them.
One aspect that has been unclear is exactly how long Sars-CoV-2, the name of the virus that causes the disease Covid-19, can survive outside the human body. Some studies on other coronaviruses, including Sars and Mers, found they can survive on metal, glass and plastic for as long as nine days, unless they are properly disinfected. Some can even hang around for up to 28 days in low temperatures. Coronaviruses are well known to be particularly resilient in terms of where they can survive. Therefore, the potential market for SiNtx’ silicon nitride could be huge.
Transparent coatings of silicon nitride could be applied to almost every surface that people in public places frequently use. A few include:
ATMs
Ticket Machines
Door Knobs
Banisters
Shopping Carts
Smartphones
Computer Keyboards in schools, libraries, etc.
Short-term Outlook:
We believe, that a market capitalization of only $5 million is too low and expect SiNtx’ stock valuation to increase significantly. It seems that the company is set to announce a number of PR’s in the near future regarding testing facilities and partners who can help examine the effect of its silicon nitride on the COVID-19 coronavirus, federal funding to support COVID-19 testing, and an invited paper that analyzes the complex granular chemistry of why silicon nitride works against bacteria, viruses, and even simple funguses. This article solely focuses on using silicon nitride against the COVID-19 coronavirus. SiNtx also has strong R&D in many other fields and is built on a solid R&D focused foundation.
|
|
|
|
Post by magnus123 on Jul 17, 2020 13:16:06 GMT
|
|
|
|
Post by JHam on Jul 17, 2020 13:27:53 GMT
Again?  The 3rd one in less than a month? That’s something...I’m not sure how I feel about it. Seems like they are really kicking shareholders below the belt. But then again maybe they know something big is about to happen with their product and will need the cash soon? |
|
|
|
Post by magnus123 on Jul 17, 2020 13:40:37 GMT
Again? The 3rd one in less than a month? That’s something...I’m not sure how I feel about it. Seems like they are really kicking shareholders below the belt. But then again maybe they know something big is about to happen with their product and will need the cash soon? I don't like it anyway. They are killing the positive momentum with It. And question for the reason is pure speculation. We don't know it. At least, the offering is not to heavy. |
|
|
|
Post by magnus123 on Jul 17, 2020 13:49:47 GMT
The offering is exclusively for institutional investors. That is maybe a little positive sign. |
|
The 3rd one in less than a month? That’s something...I’m not sure how I feel about it. Seems like they are really kicking shareholders below the belt. But then again maybe they know something big is about to happen with their product and will need the cash soon?